Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: osteoporosis

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM  |  May 9, 2012

Changing treatment paradigms in the biologic era

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorydrugJIAJuvenile idiopathic arthritismacrophage activation syndromeMethotrexatepatient carePediatricsrheumatologistSteroidstocilizumabTreatment

Drug Updates: Citalopram hydrobromide, Statins, and More

Michele B. Kaufman, PharmD, BCGP  |  May 8, 2012

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:ApprovalsBiologicsdrugJAK inhibitorsjanus kinasePipelineRheumatoid arthritisSafetyStatin

Unexpected Benefits of Bisphosphonates after Hip Fracture

Cathleen Colon-Emeric, MD, MHS  |  February 3, 2012

Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:anti-inflammatoryboneFractureship fractureOsteoporosispatient carerheumatologist

New Diagnostic Criteria for Axial Spondylarthritis

Ann Kepler  |  February 3, 2012

New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.

Filed under:Axial SpondyloarthritisClinical Criteria/GuidelinesConditions Tagged with:ACR/ARHP Annual MeetingAnkylosing Spondylitisanti-inflammatoryaxial spondyloarthritis (SpA)Diagnostic CriteriaimagingPainpatient careReactive arthritisSafety

A&R and AC&R Abstracts: Bisphosphonates

Staff  |  February 3, 2012

Want to learn more about bisphosphonates and fractures? Check out these abstracts from Arthritis & Rheumatism and Arthritis Care & Research.

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bisphosphonatesbonehip replacementimagingOsteoporosispatient careResearchrheumatologist

A Passion for Multidisciplinary Collaboration

Gretchen Henkel  |  February 3, 2012

Through teamwork, David T. Felson, MD, MPH, has advanced understanding and treatment of rheumatic diseases

Filed under:ConditionsOsteoarthritis and Bone DisordersPractice SupportProfilesResearch RheumWorkforce Tagged with:BiomarkersCareerimagingOsteoarthritisOsteoporosisPractice ManagementProfileradiographResearchrheumatologistTraining

Data-Driven, Optimal Patient Care and Clinical Research

James R. O'Dell, MD  |  January 13, 2012

Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts

Filed under:Drug UpdatesEMRsInformation TechnologyLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/ImprovementResearch RheumTechnologyTechnology Tagged with:AC&RACAAdvocacyAffordable Care Act (ACA)American College of Rheumatology (ACR)drugelectronic health recordLegislationMedicarepatient carePQRSPractice ManagementResearchrheumatologistSafetyTechnology

The Sexiness of Rheumatology

Ronan Kavanagh, MD  |  January 13, 2012

Finding the glamour in a humble field

Filed under:Career DevelopmentEducation & TrainingProfessional TopicsProfiles Tagged with:EducationPainpatient careProfilerheumatologist

Incoming ARHP Volunteers

Staff  |  January 13, 2012

Laurie Hughell, PA- C, MPH and Susan Richmond, MS, PA-C

Filed under:From the CollegeMeeting ReportsProfessional TopicsProfilesResearch Rheum Tagged with:ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)drugEducationProfileResearch

Quality Measurement Improves Rheumatology Outcomes

Kathleen Louden  |  January 13, 2012

Innovations in health information technology can have significant impact

Filed under:ConditionsDrug UpdatesInformation TechnologyMeeting ReportsOsteoarthritis and Bone DisordersPractice SupportQuality Assurance/ImprovementResearch RheumTechnologyTechnology Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)drugGlucocorticoidsOsteoporosispatient carePractice ManagementQualityRAResearchRheumatoid arthritisrheumatologistSafetyTechnology

  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 58
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences